January 8, 2008 - BodyTel Scientific Inc., (OTCBB:BDYT) the developer of wireless telemedical measuring devices, announced that its wholly owned subsidiary BodyTel Europe GmbH, legal manufacturer of the blood glucose monitoring and diabetes management system GlucoTel, has submitted the GlucoTel Technical File for regulatory review to the designated European Notified Body... BodyTel's Press Release-
Blog Archive
-
▼
2008
(233)
-
▼
January
(13)
- Medtronic, FDA Approval of CGMS iPro Continuous G...
- Arena Pharmaceuticals, APD668, Glucose-Dependent I...
- Daiichi Sankyo's Welchol, FDA Approval to Reduce B...
- Tissera , Curative Effect of Its Transplantation T...
- Incyte, HM74a agonist program for type 2 diabetes
- Echo Therapeutics, Clinical Study of Its Symphony ...
- DexCom, Joint Development Agreement with Animas Co...
- BodyTel, GlucoTel Technical Files for CE Certifica...
- Insulet and DexCom , Development Agreement
- VIVUS , Extension Study with Qnexa for Diabetes
- DiObex, Patent for the Prevention of Insulin-Induc...
- DIAMYD, PHASE III TRIAL WITH DIABETES VACCINE
- Adolor , Phase 2a Study of Delta Agonist ADL5859 i...
-
▼
January
(13)